Study design and protocol for tailored Acceptance and Commitment Therapy (ACT) to optimize quality of life in women living with metastatic breast cancer

actpapercliniciantier 3link oklink-only

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This paper outlines the rationale and study design for a pilot randomized controlled trial evaluating a tailored Acceptance and Commitment Therapy (ACT) intervention for women with metastatic breast cancer. The study aims to assess the feasibility, acceptability, and preliminary effects of an 8-week online group ACT program compared to cognitive behavioral stress management and usual care. It is intended for researchers and clinicians interested in the methodological framework for such clinical trials.

ID
d92249fa07cc4d87
Source org
OpenAlex
Author
Gilles A. Tiberghien
Published
2000-01-01
OA status
closed
DOI
10.1016/j.conctc.2021.100870
PMID
Not recorded
PMCID
Not recorded
Citations
0

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:d92249fa07cc4d87,
  title = {Study design and protocol for tailored Acceptance and Commitment Therapy (ACT) to optimize quality of life in women living with metastatic breast cancer},
  author = {Gilles A. Tiberghien},
  year = {2000},
  journal = {OpenAlex},
  doi = {10.1016/j.conctc.2021.100870},
  url = {https://doi.org/10.1016/j.conctc.2021.100870}
}

RIS

TY  - JOUR
TI  - Study design and protocol for tailored Acceptance and Commitment Therapy (ACT) to optimize quality of life in women living with metastatic breast cancer
AU  - Tiberghien, Gilles A.
PY  - 2000
PB  - OpenAlex
DO  - 10.1016/j.conctc.2021.100870
UR  - https://doi.org/10.1016/j.conctc.2021.100870
ER  -

APA

Tiberghien, G. A. (2000). Study design and protocol for tailored Acceptance and Commitment Therapy (ACT) to optimize quality of life in women living with metastatic breast cancer. OpenAlex. https://doi.org/10.1016/j.conctc.2021.100870

Related entries

More like this